Withdrawal Syndromes Lorri Beatty, MD, FRCPC Emergency Medicine February 19, 2014.

Slides:



Advertisements
Similar presentations
Alcohol: Research to Practice Gail D’Onofrio MD, MS Section of Emergency Medicine Yale University School of Medicine.
Advertisements

Best Practice Tom Shiffler, MD 7/23/10
Dosing and patient management requirements during induction, stabilization, and detoxification with buprenorphine Matthew A. Torrington MD Clinical Research.
Pharmacologic Treatments. 2 Cognitive Behavioural Therapy (CBT) Psychosocial Interventions.
Novel Opiate Detoxification Techniques Ken Roy, MD Tulane Department of Psychiatry Addiction Recovery Resources of New Orleans
Medication Assisted Treatment: An Introduction Deborah A. Orr, Ph.D., RN Remington College School of Nursing.
Toxin-Induced Seizures: Life-Threatening Forms of Withdrawl ACEP Scientific Assembly 2003, Boston, MA.
University Hospital “Sisters of Charity” Psychiatric Clinic Vinogradska c. 29, 1000 Zagreb, Croatia Davor Moravek Addiction and psychotic.
Neurological Emergencies Dr. Amal Alkhotani MBBCH, FRCPC, Epilepsy and EEG.
Serotonin syndrome: A literature review of therapeutic options? Rob Hall MD, PGY4 FRCPC Emergency Medicine Nov 8, 2003.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 7 Opioid (Narcotic) Analgesics and Antagonists.
Serotonin Syndrome Case Debrief. Case Debriefing How do you think that the case went overall? What was done well by the team leader? by the participants?
Clinical Pathological Conference Kartikya Ahuja, M.D. Resident Physician Department of Medicine NYU School of Medicine July 20 th, 2007.
Anxiety, Depression, somatization DR.YOUSEF ABDULLAH AL TURKI MBBS,DPHC,ABFM Consultant Family Medicine Associate professor King Khalid University Hospital.
O PIOID WITHDRAWALS. W ITHDRAWALS Withdrawals Detoxification is relatively a simple process - achieved by large percentage seeking Rx.
© 2011 The McGraw-Hill Companies, Inc. Instructor name Class Title, Term/Semester, Year Institution Introductory Psychology Concepts Altered Consciousness:
Major Depressive Disorder Presenting Complaints
© 2008 The McGraw-Hill Companies, Inc. Instructor name Class Title, Term/Semester, Year Institution Introductory Psychology Concepts Drug Use.
Clinical Correlations The NYU Internal Medicine Blog A Daily Dose of Medicine
Downers and Dual Recovery How do depressant drugs affect mental health?
Back to Basics Psychiatry MCQs Tin Ngo-Minh, MD R2 Psychiatry University of Ottawa.
Did he get injury? Dr. Law chi yin PYNEH. One Saturday afternoon young man age 32 Sent to AED by ambulance Fixed by spinal board and neck collar Claimed.
CIWA Protocol: Fraser Health
Jason Haag Intern Conference. Case 34 y.o. with h/o seizure disorder presents to ED with increased seizure frequency. He states he’s had 4 tonic-clonic.
for the Psychiatry Clerkship is proud to present And Now Here Is The Host... Insert Name Here.
Alcohol Withdrawal Resident Rounds July 10, 2007 Maggie Gordon, R2.
PHARMACOLOGY CNS 2 ANXIOLYTICS, HYPNOTICS AND SEDATIVES
Substance Abuse & Dependence. Substance Abuse l A residual category (i.e., a diagnosis of last resort) for patients whose substance use produces problems.
Chapter 10 - Sedatives.  Sedative-Hypnotics: calm us down and produce sleep  Antianxiety Drugs: tranquelizers.
Stimulants History: 1930’s: Benzedrine is used in inhalers, used as a cure for many of illnesses. 1940: WWII used to treat battle fatigue (pep pills) 1950’s:
Patient Assessment during Influenza Epidemics Patient Assessment during Influenza Epidemics An Outline of the Approach to Patients An Outline of the Approach.
B ENZODIAZEPINE DEPENDENCE. WHO - ICD 10 C RITERIA FOR S UBSTANCE D EPENDENCE A definite diagnosis of dependence syndrome should usually be made only.
Psychostimulants Lesson 19. Psychostimulants n Cocaine l alkaloid from coca plant n Amphetamines (synthetics) l similar fx & mechanisms l all related.
OCD, PTSD, and Panic Disorders. OCD Biological basis remains unknown But there seems to be some genetic component related to OCD and other anxiety disorders.
PIPC ® Psychiatry In Primary Care Medications Robert K. Schneider, MD Departments of Psychiatry, Internal Medicine and Family Practice The Medical College.
Medical Grand Rounds Clinical Vignette December 3, 2008 Steven Giovannone, MD.
AddictionPresentedby Dr/ Said Said Elshama Dr/ Said Said Elshama.
Anxiety A state of tension in response to real or imagined stress or danger situations. Anxiety may manifest itself as Psychic or mental state. Somatic.
Drugs Used in Mental Health Antianxiety Drugs. Anxiety – a feeling of apprehension, worry, or uneasiness that may or may not e based on reality Anxiolytics.
Opioids Unless otherwise indicated, the answers are from DSM-IV-TR and APA Practice Guidelines, AJP Supplement, August, As of 3Aug06.
ANTIDEPRESSANTS New Antidepressants.
Drugs used in Anxiety & Panic Disorders
Trazodone Mianserin Mirtazapine Tetracyclic Antidepressants Noradrenergic & Specific Serotonergic Antidepressants (NaSSAs) Serotonin Antagonists & Reuptake.
James B. Ray, PharmD, CPE The James A. Otterbeck Professor of Hospice & Palliative Care University of Iowa College of Pharmacy 11/18/2015.
WELCOME BACK.
Addiction and dependence Disclaimer: This presentation contains information on the general principles of pain management. This presentation cannot account.
بسم الله الرحمن الرحيم Dr: Samah Gaafar Hassan Al-shaygi.
Clinical Management Course: Medical Complications of Alcoholism Peter R. Martin, M.D. Professor of Psychiatry and Pharmacology.
TM The EPEC-O Project Education in Palliative and End-of-life Care - Oncology The EPEC TM -O Curriculum is produced by the EPEC TM Project with major funding.
Samantha Allen PharmD Candidate 2012 Case Presentation April 19, 2012 Alcohol Withdrawal Management.
Managing Alcohol and Opioid Withdrawals
Seizures LMH ER Rounds March 22, 2016 Prepared by Shane Barclay.
Substance Abuse Chapter 11. Substance Abuse  Self-administration of a drug in a manner that does not conform to the norms within the patient’s own culture.
 Discuss the symptoms and signs of alcohol withdrawal.  Discuss the management of alcohol withdrawal.
Drugs used for anxiety and panic disorders
Drugs used for anxiety and panic disorders
Clinical Opiate Withdrawal – Symptom Management Protocol
Tapering Opioids (1) C.L.I.P.S.
Update Training on CIWA and COWS
Altering Consciousness through Drugs
Alcohol Withdrawal in Acute Care
UCI internal medicine mini-lecture series By Julia Kao
Presented by J. Arzaga, MSN, RN
Treating Opioid Withdrawal with Buprenorphine/Naloxone
Antidepressant Discontinuation Syndrome
Evaluation and Management of Pediatric Seizures
High-Yield Terms to Learn Abstinence syndrome  A term used to describe the signs and symptoms that occur on withdrawal.
Treating Opioid Withdrawal with Buprenorphine/Naloxone
Question 11 – Methadone overdose
Acute Pain Management & Addiction
Presentation transcript:

Withdrawal Syndromes Lorri Beatty, MD, FRCPC Emergency Medicine February 19, 2014

Disclosures Sadly, none.

Objectives By the end of this presentation, participants will be able to: – Recognise and treat acute opioid withdrawal – Describe the features of ethanol and benzodiazepine withdrawal – Use first- and second-line approaches to treat alcohol and benzodiazepine withdrawal – Recognise and manage antidepressant discontinuation syndrome – Describe cocaine washout

Case 1 64 ♂ with prostate cancer, mets to pelvis and spine (followed by Palliative Care) 3 day history of nausea, vomiting, diarrhea Now worsening back pain, myalgias, abdominal cramps, runny nose, restlessness Followed by palliative care

Case 1 (continued) HR 106 BP 106/56 RR 20 SaO 2 98% T 37.2° Looks unwell, cachectic, uncomfortable Diffuse muscle tenderness Med list: – hydromorph contin 24mg BID- lactulose 30mg BID – hydromorphone 4mg q2h PRN- metoclopramide 10mg QID – acetominophen 650mg QID

Case 2 32 ♀ in methadone program for 14 months – Doing well Stopped methadone 4 days ago as “I don’t want to be a druggie anymore” Now nausea, abdominal pain, loose stool, insomnia since yesterday

Case 2 (continued) HR 96 BP 148/82 RR 22 SaO 2 97% T 36.6° On exam – Well-hydrated, looks uncomfortable, irritable mydriasis, yawning++, piloerection, ++ bowel sounds Normal muscle tone, normal skin, reflexes 2+, no tremor

Opioid Withdrawal - Mechanism

Opioid Withdrawal - Symptoms Autonomic: – Yawning, sneezing, lacrimation, rhinorrhea, mydriasis – ↑HR (mild), ↑BP (mild), ↑RR (mild), ↑T° (if severe) Neuro/mood: – Dysphoria, anxiety, restlessness, insomnia – NORMAL level of consiousness, NORMAL motor exam Somatic: – Myalgias, arthralgias, piloerection GI: – Nausea, vomiting, diarrhea, abdominal cramps, ↑MS

Opioid Withdrawal - Management 1) Use opioids 2) Treat Symptoms 3) Replace opioids

Restart usual dose if able Consider alternate route if can’t take PO – SC, IM, IV, transdermal Methadone – Consider using lower dose – 20mg PO or 10mg IM 1) Use opioids

2) Treat Symptoms DrugDoseSymptoms Diazepam1 – 10mg PO/IM/IV Anxiety, restlessness, muscle cramps, insomnia Gravol25 – 50mg PO/IM/IVNausea, vomiting Loperamide4mg PO then 2mg PRNAbdominal cramps, diarrhea Acetaminophen, ibuprofen Pain

Clonidine Mechanism: – 2-agonist, opens similar K+-channels Symptoms: – restlessness, dysphoria, GI symptoms Dosing: – 0.1 – 0.2mg PO q1-2h PRN in ED (monitor BP!) – 0.1 – 0.2mg PO q6h x 3 – 4 doses to go Risks – hypotension, sedation 3) Replace opioids

Case 3 31 ♀, 3 visits in last 10 days for non-specific complaints Presents at 0900 with sore throat, trouble breathing, nausea Denies any PMHx, no meds, no allergies, smoker, social drinker Looks unwell, placed in resuscitation room

Case 3 (continued) HR 120 BP 166/88 RR 24 SaO 2 97% T 38.2° Looks anxious, tripod posture, mild respiratory distress, agitated, slightly confused On exam – normal oropharynx, chest clear, S 1 S 2 normal with no murmur, bounding pulses Skin flushed & diaphoretic; pupils equal & reactive; mild tremor; slightly increased tone

Case 3 (continued) CXR – normal EKG – sinus tachycardia Labs – normal, d-dimer negative While in ED patient becomes more agitated, anxious, worsening respiratory distress HR 154 BP 178/94 RR 30 SaO 2 97% T 38.7°

Case 4 (continued) Given ceftriaxone, acyclovir, vancomycin CT head arranged – patient unable to lie flat – intubated for CT – Propofol, succinylcholine; propofol drip started CT head negative LP attempted, patient +++ agitated despite 250mg/hour propofol → midazolam 5mg IV HR 110 BP 136/86 RR vent SaO 2 98% T 38.9°

Case 5 76 brought to ED by EHS after neighbours hadn’t seen him in 2 days Found in apartment – dishevelled, incontinent, confused HR 106 BP 148/74 RR 20 SaO 2 95% T 37.1°

Case 5 (continued) GCS 14, not oriented to place or time, appears anxious, agitated No evidence of trauma Tremor; nil focal on neuro exam Pharmacy tech provides medication list: – Metformin, ASA, Lipitor, clonazepam – Not filled this month

Alcohol Withdrawal - Mechanism Finn DA, Crabbe JC. Alcohol Health and Research World, 1997, 21(2):

Alcohol Withdrawal – Mechanism Finn DA, Crabbe JC. Alcohol Health and Research World, 1997, 21(2):

Alcohol Withdrawal – Clinical Features Autonomic Dysfunction -↑HR, ↑BP, ↑T° -tremor, increased tone, mydriasis -altered level of consiousness Seizure -T/C, single, brief -short post-ictal period CNS Excitation -nausea, vomiting -↑HR, ↑BP -tremor, increased tone, diaphoresis Hallucinations -visual -auditory -tactile

Alcohol Withdrawal - Management 1) Benzodiazepines 2) Fluids/electrolytes 3) Nutritional deficiencies

Diazepam (Valium) is best choice – 5 – 10mg PO or IV – Quick onset (<30 minutes) – LONG halflife (33 hours; up to 50 hours for metabolites) Front loading is better – Quicker improvement of symptoms – Less overall drug 1) Benzodiazepines

CIWA Scale

Elevated temperature, respiratory rate and sweating → ++ fluids losses – Severely ill patients may be normo- or hypotensive Check lytes if unwell, unstable, altered LOC Remember magnesium! 2) Fluids/electrolytes

Thiamine – Often thiamine deficient – Required to run Krebs cycle – Lack of thiamine → Wernicke/Korsakoff syndromes Glucose – Required to maintain high metabolic rate Folate/multivitamin – Often replace food with alcohol 3) Nutritional deficiencies

Barbituates Actively opens GABA channels Risk of sedation, hypotension, respiratory depression Phenobarbital 60 – 120mg IV q30min Propofol Acts on GABA and NMDA receptor Risk of sedation, hypotension, respiratory depression AVOID Antipsychotics, clonidine, β-blockers What if that doesn’t work???

Antidepressant Discontinuation Syndrome - Mechanism Long-term use (> 6 weeks) ↑ serotonin in synapse Downregulation of receptors

Antidepressant Discontinuation Syndrome - Symptoms Neuro: – Dizzyness, headache, tremor, paresthesias, “electric shocks”, myoclonus, ataxia, vision changes Mood: – anxiety/hyperarousal, dysphoria, insomnia, lethagy GI: – Nausea, diarrhea, GI upset Onset: days Duration: weeks

Antidepressant Discontinuation Syndrome - Management 1) Restart SSRI Restart previous dose, gradual taper 2) Treat Symptoms 3) Replace SSRI Switch to fluoxetine 20mg with taper

From: Harvard Women’s Health Watch, November 2010

Cocaine “Withdrawal” Cocaine – ↑ dopamine, NE, serotonin – Short-term use – euphoria, CNS stimulant – Long-term use exhausts stores Cocaine Abstinence – NOT withdrawal – NOT dangerous – FEW physical symptoms Cocaine Abstinence Syndrome

Three Stages of Cocaine Abstinence Stage 1 – Cocaine Crash (1 – 4 days) Profound lack of neurotransmitters Dysphoria, anxiety, irritability, hypersomnia, exhaustion, increased appetite, cravings Stage 2 – Cocaine Washout (1 – 10 weeks) Gradual recovery of neurotransmitters Anergia, listlessness, depression Gradual ↑ in concentration, ↓ in cravings Stage 3 - Extinction

In Conclusion... Opioid Withdrawal – Restart if possible/indicated – Methadone – use 20mg PO or 10mg IM – Consider clonidine Alcohol/Benzodiazepine Withdrawal – Benzos, benzos, benzos – Valium – repeat doses until asymptomatic – Remember fluid and nutrition replacement

In Conclusion... Antidepressant Discontinuation Syndrome – Have a low threshold; ask about SSRIs – Restart drug with a slow taper, or treat symptoms Cocaine Abstinence Syndrome – Largely psychological symptoms, depression – Not life-threatening, and few clinical symptoms – Treat symptomatically if needed